RFLRafael Holdings, Inc.

NYSE www.rafaelholdings.com


$ 1.67 $ 0.01 (0.63 %)    

Tuesday, 07-May-2024 15:37:32 EDT
QQQ $ 441.33 $ 0.87 (0.2 %)
DIA $ 394.43 $ 3.52 (0.9 %)
SPY $ 520.56 $ 3.37 (0.65 %)
TLT $ 90.69 $ 0.50 (0.55 %)
GLD $ 216.93 $ 3.37 (1.58 %)
$ 1.59
$ 1.68
$ 0.00 x 0
$ 0.00 x 0
$ 1.67 - $ 1.68
$ 1.44 - $ 2.52
8,650
na
39.29M
$ 1.32
$ 9.64
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-14-2024 01-31-2024 10-Q
2 12-14-2023 10-31-2023 10-Q
3 10-30-2023 07-31-2023 10-K
4 06-13-2023 04-30-2023 10-Q
5 03-14-2023 01-31-2023 10-Q
6 12-13-2022 10-31-2022 10-Q
7 10-31-2022 07-31-2022 10-K
8 06-14-2022 04-30-2022 10-Q
9 03-17-2022 01-31-2022 10-Q
10 12-15-2021 10-31-2021 10-Q
11 10-18-2021 07-31-2021 10-K
12 06-14-2021 04-30-2021 10-Q
13 03-17-2021 01-31-2021 10-Q
14 12-15-2020 10-31-2020 10-Q
15 10-29-2020 07-31-2020 10-K
16 06-09-2020 04-30-2020 10-Q
17 03-05-2020 01-31-2020 10-Q
18 12-09-2019 10-31-2019 10-Q
19 10-04-2019 07-31-2019 10-K
20 06-05-2019 04-30-2019 10-Q
21 03-12-2019 01-31-2019 10-Q
22 12-10-2018 10-31-2018 10-Q
23 10-15-2018 07-31-2018 10-K
24 06-11-2018 04-30-2018 10-Q
25 03-12-2018 01-31-2018 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 rafael-holdings-q4-eps-006-up-from-024-yoy-sales-6800k-down-from-6900k-yoy

Rafael Holdings (NYSE:RFL) reported quarterly earnings of $0.06 per share. This is a 125 percent increase over losses of $(0.24...

Core News & Articles

Continued strong enrollment of pivotal Phase 3 global study (TransportNPC™) evaluating Trappsol® Cyclo™ for Niemann-Pick Diseas...

 rafael-holdings-q3-eps-006-up-from-028-yoy

Rafael Holdings (NYSE:RFL) reported quarterly losses of $(0.06) per share. This is a 78.57 percent increase over losses of $(0....

 rafael-holdings-announces-up-to-5m-share-repurchase-program

Rafael Holdings, Inc. (NYSE:RFL), today announced that its Board of Directors has authorized the repurchase of up to $5 million...

 rafael-holdings-q2-eps-014-down-from-012-yoy

Rafael Holdings (NYSE:RFL) reported quarterly losses of $(0.14) per share. This is a 16.67 percent decrease over losses of $(0....

 top-real-estate-stocks-that-may-plunge

The most overbought stocks in the real estate sector presents an opportunity to go short on these overvalued companies.

 rafael-says-effective-jan-27-2023-chief-financial-officer-patrick-fabbio-to-depart-co

-SEC Filing

 rafael-holdings-q1-eps-022-up-from-075-yoy

Rafael Holdings (NYSE:RFL) reported quarterly losses of $(0.22) per share. This is a 70.67 percent increase over losses of $(0....

 rafael-holdings-to-focus-on-strategic-business-development-initiatives-and-curtail-early-stage-development-activities-as-of-july-31-2022-the-company-held-cash-cash-equivalents-and-marketable-securities-of-632m

Rafael Holdings, Inc. (NYSE:RFL) today announced its decision to curtail its early-stage development efforts, including pre-cli...

 rafael-pharmaceuticals-has-received-a-notice-of-allowance-for-its-us-patent-application-17261237-titled-therapeutic-methods-and-compositions-for-treating-pancreatic-cancer-using-68-bis-benzylthio-octanoic-acid---uspto

https://patentcenter.uspto.gov/#!/applications/17261237/ifw/docs

 rafael-holdings-q4-eps-024-up-from-075-yoy

Rafael Holdings (NYSE:RFL) reported quarterly losses of $(0.24) per share. This is a 68 percent increase over losses of $(0.75)...

 cornerstone-pharmaceuticals-announces-successful-completion-of-phase-1b-clinical-trial-for-cpi-613-in-combination-with-gemcitabine-and-cisplatin-in-patients-with-biliary-tract-cancer

Cornerstone Pharmaceuticals, Inc. (“Cornerstone” or the “Company”), a company focused on rare cancer therapeutics and formerly ...

 alibaba-zoom-video-and-76-biggest-movers-from-yesterday

Gainers Kaspien Holdings Inc. (NASDAQ: KSPN) shares climbed 161.9% to close at $6.81 on Monday on heavy volume amid mention ...

 why-these-casino-stocks-are-moving-lower-heres-45-stocks-moving-in-mondays-mid-day-session

Gainers Pliant Therapeutics, Inc. (NASDAQ: PLRX) jumped 112.6% to $18.88 after the company said its treatment for Idiopathi...

 more-than-27-million-bet-on-seres-therapeutics-4-penny-stocks-insiders-are-buying

U.S. stock futures traded lower this morning on Friday ahead of jobs report for june. Investors, meanwhile, focused on some not...

 rafael-holdings-q3-eps-028-down-from-015-yoy

Rafael Holdings (NYSE:RFL) reported quarterly losses of $(0.28) per share. This is a 86.67 percent decrease over losses of $(0....

 cornerstone-pharma-formerly-rafael-pharma-reports-european-medicines-agency-granted-orphan-drug-designation-for-cos-devimistat-for-treatment-of-patients-with-advanced-unresectable-biliary-tract-cancer

 Cornerstone Pharmaceuticals, Inc. ("Cornerstone" or the "Company"), a company focused on rare cancer therapeut...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION